Literature DB >> 30615954

Optimal strategies for the prevention of heterotopic ossification after total hip arthroplasty: A network meta-analysis.

Liyang Cai1, Zhan Wang1, Xiangli Luo1, Wei She1, Hui Zhang2.   

Abstract

BACKGROUND: Nonselective nonsteroidal anti-inflammatory drugs (NSAIDs), selective NSAIDs, and radiation are widely used for the prevention of heterotopic ossification (HO) after total hip arthroplasty (THA). Previous studies have suggested that nonselective NSAIDs, selective NSAIDs and radiation can prevent HO after THA, though the results are conflicting. In this network meta-analysis, we aimed to comprehensively analyze the efficacy and safety of three strategies for preventing HO after THA compared to a placebo. PATIENTS AND METHODS: Relevant studies about nonselective NSAIDs, selective NSAIDs, radiation and controls that were used to prevent HO after THA were collected. Data were extracted independently by two reviewers. Network meta-analysis was applied to assess treatment efficacy and safety. The surface under the cumulative ranking curve (SUCRA) method was used to assess which treatment was ranked the highest. The node-splitting method was used to calculate inconsistency.
RESULTS: Radiation was found to be the most efficient option for preventing overall incidence of HO and Brooker IV, I, II and III HO after THA. Selective NSAIDs were the safest option, and radiation was ranked second for preventing HO after THA, as the treatments were ranked taking discontinuation caused by nongastrointestinal side effects (DNGSE) and the incidence of complications into consideration.
CONCLUSIONS: A network meta-analysis concluded that radiation is the most efficacious method for preventing HO after THA.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Keywords:  Heterotopic ossification; Network meta-analysis; Nonsteroidal anti-inflammatory drugs; Radiation

Mesh:

Substances:

Year:  2019        PMID: 30615954     DOI: 10.1016/j.ijsu.2018.12.011

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  5 in total

Review 1.  Prophylactic Radiotherapy of Hip Heterotopic Ossification: A Narrative Mini Review.

Authors:  Massimiliano De Paolis; Alessio Giuseppe Morganti; Erika Galietta; Luca Gaiani; Claudio Giannini; Andrea Sambri; Milly Buwenge; Gabriella Macchia; Francesco Deodato; Savino Cilla; Lidia Strigari; Michele Fiore; Silvia Cammelli
Journal:  In Vivo       Date:  2022 Mar-Apr       Impact factor: 2.155

2.  Heterotopic ossification in primary total hip arthroplasty: risk factor analysis.

Authors:  Alessandro Aprato; Simone Cambursano; Stefano Artiaco; Stefano Bevilacqua; Paolo Catalani; Alessandro Massè
Journal:  Eur J Orthop Surg Traumatol       Date:  2022-03-19

3.  Identification of Risk Factors in the Development of Heterotopic Ossification After Primary Total Hip Arthroplasty.

Authors:  Sukhmani Singh; Saam Morshed; Daria Motamedi; Joseph Kidane; Alexandra Paul; Edward C Hsiao; Kelly L Wentworth
Journal:  J Clin Endocrinol Metab       Date:  2022-08-18       Impact factor: 6.134

4.  Bilateral hip heterotopic ossification with sciatic nerve compression on a paediatric patient-An individualized surgical approach: A case report.

Authors:  João Pedro Gouveia Nóbrega; Pedro Jordão; Joana Arcângelo
Journal:  World J Orthop       Date:  2022-08-18

5.  NSAIDs for Prophylaxis for Heterotopic Ossification After Total Hip Arthroplasty: A Bayesian Network Meta-analysis.

Authors:  Filippo Migliorini; Andromahi Trivellas; Jörg Eschweiler; Arne Driessen; Markus Tingart; Nicola Maffulli
Journal:  Calcif Tissue Int       Date:  2020-10-12       Impact factor: 4.333

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.